NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
3.640
+0.030 (0.83%)
At close: Dec 5, 2025, 4:00 PM EST
3.330
-0.310 (-8.52%)
After-hours: Dec 5, 2025, 5:40 PM EST
NewcelX Statistics
Total Valuation
NewcelX has a market cap or net worth of $16.59 million. The enterprise value is $18.57 million.
| Market Cap | 16.59M |
| Enterprise Value | 18.57M |
Important Dates
The last earnings date was Monday, December 1, 2025.
| Earnings Date | Dec 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NewcelX has 4.56 million shares outstanding. The number of shares has increased by 0.88% in one year.
| Current Share Class | 4.56M |
| Shares Outstanding | 4.56M |
| Shares Change (YoY) | +0.88% |
| Shares Change (QoQ) | +3.05% |
| Owned by Insiders (%) | 54.40% |
| Owned by Institutions (%) | 0.32% |
| Float | 2.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -50.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -155.19% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 16.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.23M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -24,337 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 25.37 |
| Average Volume (20 Days) | 39,988 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.55M |
| Pretax Income | -18.51M |
| Net Income | -18.49M |
| EBITDA | -2.71M |
| EBIT | -2.55M |
| Earnings Per Share (EPS) | -$4.32 |
Balance Sheet
The company has $299,172 in cash and $2.55 million in debt, giving a net cash position of -$2.25 million or -$0.49 per share.
| Cash & Cash Equivalents | 299,172 |
| Total Debt | 2.55M |
| Net Cash | -2.25M |
| Net Cash Per Share | -$0.49 |
| Equity (Book Value) | -15.09M |
| Book Value Per Share | -3.35 |
| Working Capital | -15.20M |
Cash Flow
In the last 12 months, operating cash flow was -$638,708 and capital expenditures -$1,484, giving a free cash flow of -$666,656.
| Operating Cash Flow | -638,708 |
| Capital Expenditures | -1,484 |
| Free Cash Flow | -666,656 |
| FCF Per Share | -$0.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NewcelX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.88% |
| Shareholder Yield | -0.88% |
| Earnings Yield | -113.30% |
| FCF Yield | -4.09% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |